133 related articles for article (PubMed ID: 38381650)
1. Structure-Activity Relationship Studies and Optimization of 4-Hydroxypyridones as GPR84 Agonists.
Ieremias L; Kaspersen MH; Manandhar A; Schultz-Knudsen K; Vrettou CI; Pokhrel R; Heidtmann CV; Jenkins L; Kanellou C; Marsango S; Li Y; Bräuner-Osborne H; Rexen Ulven E; Milligan G; Ulven T
J Med Chem; 2024 Mar; 67(5):3542-3570. PubMed ID: 38381650
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84.
Liu H; Zhang Q; He X; Jiang M; Wang S; Yan X; Cheng X; Liu Y; Nan FJ; Xu HE; Xie X; Yin W
Nat Commun; 2023 Jun; 14(1):3271. PubMed ID: 37277332
[TBL] [Abstract][Full Text] [Related]
3. Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists.
Wang P; Raja A; Luscombe VB; Bataille CJR; Lucy D; Rogga VV; Greaves DR; Russell AJ
J Med Chem; 2024 Jan; 67(1):110-137. PubMed ID: 38146625
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of 2-Alkylpyrimidine-4,6-diol and 6-Alkylpyridine-2,4-diol as Potent GPR84 Agonists.
Liu Y; Zhang Q; Chen LH; Yang H; Lu W; Xie X; Nan FJ
ACS Med Chem Lett; 2016 Jun; 7(6):579-83. PubMed ID: 27326330
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of GPR84 in domestic cats.
Yamamoto I; Michishita M; Fujita K; Sakai T; Sasaki N; Kawasumi K
Gen Comp Endocrinol; 2024 Jul; 353():114520. PubMed ID: 38641150
[TBL] [Abstract][Full Text] [Related]
6. 20 Years an Orphan: Is GPR84 a Plausible Medium-Chain Fatty Acid-Sensing Receptor?
Luscombe VB; Lucy D; Bataille CJR; Russell AJ; Greaves DR
DNA Cell Biol; 2020 Nov; 39(11):1926-1937. PubMed ID: 33001759
[TBL] [Abstract][Full Text] [Related]
7. 6-(Ar)Alkylamino-Substituted Uracil Derivatives: Lipid Mimetics with Potent Activity at the Orphan G Protein-Coupled Receptor 84 (GPR84).
Pillaiyar T; Köse M; Namasivayam V; Sylvester K; Borges G; Thimm D; von Kügelgen I; Müller CE
ACS Omega; 2018 Mar; 3(3):3365-3383. PubMed ID: 30023867
[TBL] [Abstract][Full Text] [Related]
8. Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor.
Gaidarov I; Anthony T; Gatlin J; Chen X; Mills D; Solomon M; Han S; Semple G; Unett DJ
Pharmacol Res; 2018 May; 131():185-198. PubMed ID: 29471103
[TBL] [Abstract][Full Text] [Related]
9. The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis.
Puengel T; De Vos S; Hundertmark J; Kohlhepp M; Guldiken N; Pujuguet P; Auberval M; Marsais F; Shoji KF; Saniere L; Trautwein C; Luedde T; Strnad P; Brys R; Clément-Lacroix P; Tacke F
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32316235
[TBL] [Abstract][Full Text] [Related]
10. Investigating the Structure-Activity Relationship of 1,2,4-Triazine G-Protein-Coupled Receptor 84 (GPR84) Antagonists.
Mahindra A; Jenkins L; Marsango S; Huggett M; Huggett M; Robinson L; Gillespie J; Rajamanickam M; Morrison A; McElroy S; Tikhonova IG; Milligan G; Jamieson AG
J Med Chem; 2022 Aug; 65(16):11270-11290. PubMed ID: 35948061
[TBL] [Abstract][Full Text] [Related]
11. Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R.
Sundqvist M; Christenson K; Holdfeldt A; Gabl M; Mårtensson J; Björkman L; Dieckmann R; Dahlgren C; Forsman H
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):695-708. PubMed ID: 29477577
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the G-Protein-Coupled Receptor 84 (GPR84) by Agonists and Antagonists.
Chen LH; Zhang Q; Xie X; Nan FJ
J Med Chem; 2020 Dec; 63(24):15399-15409. PubMed ID: 33267584
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Characterization of a Novel Small-Molecule Agonist for Medium-Chain Free Fatty Acid Receptor G Protein-Coupled Receptor 84.
Zhang Q; Yang H; Li J; Xie X
J Pharmacol Exp Ther; 2016 May; 357(2):337-44. PubMed ID: 26962172
[TBL] [Abstract][Full Text] [Related]
14. GPR84 in physiology-Many functions in many tissues.
Aktar R; Rondinelli S; Peiris M
Br J Pharmacol; 2024 May; 181(10):1524-1535. PubMed ID: 37533166
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis and molecular modeling for the investigation of ligand-binding modes of GPR84.
Nikaido Y; Koyama Y; Yoshikawa Y; Furuya T; Takeda S
J Biochem; 2015 May; 157(5):311-20. PubMed ID: 25425658
[TBL] [Abstract][Full Text] [Related]
16. Biased agonists of GPR84 and insights into biological control.
Luscombe VB; Wang P; Russell AJ; Greaves DR
Br J Pharmacol; 2024 May; 181(10):1509-1523. PubMed ID: 38148720
[TBL] [Abstract][Full Text] [Related]
17. Diindolylmethane Derivatives: Potent Agonists of the Immunostimulatory Orphan G Protein-Coupled Receptor GPR84.
Pillaiyar T; Köse M; Sylvester K; Weighardt H; Thimm D; Borges G; Förster I; von Kügelgen I; Müller CE
J Med Chem; 2017 May; 60(9):3636-3655. PubMed ID: 28406627
[TBL] [Abstract][Full Text] [Related]
18. A Biased Agonist at Immunometabolic Receptor GPR84 Causes Distinct Functional Effects in Macrophages.
Lucy D; Purvis GSD; Zeboudj L; Chatzopoulou M; Recio C; Bataille CJR; Wynne GM; Greaves DR; Russell AJ
ACS Chem Biol; 2019 Sep; 14(9):2055-2064. PubMed ID: 31465201
[TBL] [Abstract][Full Text] [Related]
19. GRK2 selectively attenuates the neutrophil NADPH-oxidase response triggered by β-arrestin recruiting GPR84 agonists.
Fredriksson J; Holdfeldt A; Mårtensson J; Björkman L; Møller TC; Müllers E; Dahlgren C; Sundqvist M; Forsman H
Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119262. PubMed ID: 35341806
[TBL] [Abstract][Full Text] [Related]
20. The Two Formyl Peptide Receptors Differently Regulate GPR84-Mediated Neutrophil NADPH Oxidase Activity.
Mårtensson J; Sundqvist M; Manandhar A; Ieremias L; Zhang L; Ulven T; Xie X; Björkman L; Forsman H
J Innate Immun; 2021; 13(4):242-256. PubMed ID: 33789297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
